SURGICAL OUTCOMES IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY AND FIDUCIAL TARGETED IGRT: AN INSTITUTIONAL EXPERIENCE

被引：0
|
作者：
Sharma, Manav
Singh, Shailendra
Rao, Bharat
Kirichenko, Alexander
Morrissey, Suzanne
Mitre, Marcia
Garg, Mrinal
Kumar, Ujjala
Kulkarni, Abhijit
Monga, Dulabh
Schiffman, Suzanne
Williams, Harry K.
Atkinson, Donald
Lupetin, Anthony
Dhawan, Manish
Thakkar, Shyam
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31222-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1324
引用
收藏
页码：S276 / S277
页数：2
相关论文
共 50 条
  • [31] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Ammar A. Javed
    Michael J. Wright
    Ayat Siddique
    Alex B. Blair
    Ding Ding
    Richard A. Burkhart
    Martin Makary
    John L. Cameron
    Amol Narang
    Joseph Herman
    Lei Zheng
    Daniel Laheru
    Matthew J. Weiss
    Christopher Wolfgang
    Jin He
    Journal of Gastrointestinal Surgery, 2019, 23 : 112 - 121
  • [32] The Paradigm Shift of Neoadjuvant FOLFIRINOX: Surgical Outcomes of Borderline Resectable and Unresectable Pancreatic Cancer
    Dias-Santos, D.
    Hong, T. S.
    Faris, J.
    Kwak, E.
    Deshpand, V.
    Wo, J.
    Wargo, J.
    Allen, J.
    Blaszkowsky, L.
    Ting, D.
    Ryan, D. P.
    Forcione, D.
    Thayer, S. P.
    Fernandez-del Castillo, C.
    Warshaw, A. L.
    Lillemoe, K. D.
    Ferrone, C. R.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S21 - S22
  • [33] Long-term outcomes with neoadjuvant chemotherapy with or without stereotactic body radiation therapy in patients with borderline resectable and locally advanced pancreatic adenocarcinoma
    Hill, Colin
    Rosati, Lauren M.
    Hu, Chen
    Fu, Wei
    Sehgal, Shuchi
    Hacker-Prietz, Amy
    He, Jin
    Laheru, Daniel A.
    Zheng, Lei
    Burkhart, Richard A.
    De Jesus-Acosta, Ana
    Le, Dung T.
    Hruban, Ralph H.
    Weiss, Matthew John
    Wolfgang, Christopher Lee
    Narang, Amol
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [34] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Hu, Qiancheng
    Wang, Dan
    Chen, Ye
    Li, Xiaofen
    Cao, Peng
    Cao, Dan
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [35] Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
    Shaina Templeton
    Michael Moser
    Chris Wall
    John Shaw
    Haji Chalchal
    Yigan Luo
    Adnan Zaidi
    Shahid Ahmed
    Journal of Gastrointestinal Cancer, 2021, 52 : 529 - 535
  • [36] Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Chandana, Sreenivasa
    Eastburg, Benjamin
    Frisch, Austin
    Parker, Jessica
    Wright, G. Paul
    Assifi, M. Mura
    Chung, Mathew
    AMERICAN SURGEON, 2024, 90 (11) : 2762 - 2768
  • [37] Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
    Templeton, Shaina
    Moser, Michael
    Wall, Chris
    Shaw, John
    Chalchal, Haji
    Luo, Yigan
    Zaidi, Adnan
    Ahmed, Shahid
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (02) : 529 - 535
  • [38] Single Institution Experience With Neoadjuvant Treatment of Borderline Resectable Pancreatic Adenocarcinoma: Achieving R0 Resection With Modern Chemotherapy
    Bolton, Nathan
    Conway, William C.
    Bolton, John S.
    GASTROENTEROLOGY, 2014, 146 (05) : S1018 - S1018
  • [39] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Qiancheng Hu
    Dan Wang
    Ye Chen
    Xiaofen Li
    Peng Cao
    Dan Cao
    Radiation Oncology, 14
  • [40] Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
    Mellon, Eric A.
    Hoffe, Sarah E.
    Springett, Gregory M.
    Frakes, Jessica M.
    Strom, Tobin J.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Chuong, Michael D.
    Shridhar, Ravi
    ACTA ONCOLOGICA, 2015, 54 (07) : 979 - 985
12345